Skip to Content Skip to Search

Our policy advocacy

Policies, codes and standards

We believe how we deliver is just as important as what we deliver.

To achieve our mission to help people do more, feel better and live longer, we rely those inside and outside our company to work responsibly and adhere to set standards that reflect our company ethos and values.

Our values are enforced through our Company Code of Conduct, robust compliance processes and adherence to peak body standards as set out by the Medicines Australia Code of Conduct and the Australian Self Medication Industry standards.

Read our global policies for more information on the industry codes and standards which GSK operates under. 

 

Submissions to government

National Medicines Policy

As a long-standing partner in the National Medicines Policy (NMP), GSK Australia recognises the policy’s importance and support its overarching aim to deliver positive health outcomes for all Australians through their access to and appropriate use of medicines. We welcomed the invitation to have input into the Review of the NMP.

GSK Australia Submission: Review of the National Medicines Policy (PDF 493 KB)

Back to top

The Australian Cancer Plan 2022-2033

GSK Australia Submission: Productivity Inquiry

GSK Australia Submission: Review of the Discount Rate in PBAC Guidelines

GSK Australia Submission: Review of the Discount Rate in PBAC Guidelines Phase Two

GSK Australia welcomes the opportunity to have further input into the Pharmaceutical Benefits Advisory Committee (PBAC)’s review of the base discount rate. We support the Medicines Australia submission to the PBAC on the Base Case Discount Rate1 calling for the discount rate to be lowered to 1.5%. As stated in the Medicines Australia submission, a reduced discount rate would align with international best practice, and better reflect the value of preventative medicines to the community, health system and economy.

GSK Australia Submission: Review of the Discount Rate in PBAC Guidelines Phase Two

Back to top

GSK response to the Australian Government consultation on the Onsite Aged Care Pharmacist Program

GSK Australia supports the Australian Government’s implementation of a new measure to embed pharmacists
in residential aged care homes to improve medication management and safety. We call on the Government to
expand this role beyond medicine management to include the delivery of National Immunisation Program and
private market vaccinations.

GSK response to the Australian Government consultation on the Onsite Aged Care Pharmacist Program

Back to top